Results 1 - 20 of 11,559 for All Library Resources
Sorted by:
Sorted by:
PopularityOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
Refined by:
subject:
Research & Development
Coronaviruses
Coronaviruses
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19PLoS pathogens, 2020-10, Vol.16 (10), p.e1008902-e1008902 [Peer Reviewed Journal]COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Kinsella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Kinsella et al 2020 Kinsella et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1008902 ;PMID: 33035262Full text available |
| 2 |
Material Type: Article
|
|
Global cancer research in the post-pandemic worldThe lancet oncology, 2021-12, Vol.22 (12), p.1652-1654 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00602-1 ;PMID: 34856137Full text available |
| 3 |
Material Type: Article
|
|
The COVID-19 Innovation SystemHealth affairs (Millwood, Va.), 2021-03, Vol.40 (3), p.400-5 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Mar 2021 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2020.02097 ;PMID: 33539184Full text available |
| 4 |
Material Type: Article
|
|
Reboot biomedical R&D in the global public interestNature (London), 2022-02, Vol.602 (7896), p.207-210 [Peer Reviewed Journal]Copyright Nature Publishing Group Feb 10, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-00324-y ;PMID: 35140380Full text available |
| 5 |
Material Type: Article
|
|
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster VaccinationNew England Journal of Medicine, 2022-03, Vol.386 (11), p.1088-1091 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119912 ;PMID: 35081298Digital Resources/Online E-Resources |
| 6 |
Material Type: Article
|
|
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort studyThe Lancet (British edition), 2021-08, Vol.398 (10302), p.747-758 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01755-4 ;PMID: 34454673Full text available |
| 7 |
Material Type: Article
|
|
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyThe Lancet (British edition), 2021-07, Vol.398 (10296), p.213-222 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01429-X ;PMID: 34246358Full text available |
| 8 |
Material Type: Article
|
|
A minimal common outcome measure set for COVID-19 clinical researchThe Lancet infectious diseases, 2020-08, Vol.20 (8), p.e192-e197 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30483-7 ;PMID: 32539990Full text available |
| 9 |
Material Type: Article
|
|
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020Emerging infectious diseases, 2020-07, Vol.26 (7), p.1583-1591 [Peer Reviewed Journal]COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;Published 2020. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2607.200885 ;PMID: 32275497Full text available |
| 10 |
Material Type: Article
|
|
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialThe Lancet infectious diseases, 2021-06, Vol.21 (6), p.803-812 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30987-7 ;PMID: 33548194Full text available |
| 11 |
Material Type: Article
|
|
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020-05, Vol.395 (10236), p.1569-1578 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31022-9 ;PMID: 32423584Digital Resources/Online E-Resources |
| 12 |
Material Type: Article
|
|
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine SerumNew England Journal of Medicine, 2021-12, Vol.385 (25), p.2397-2399 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2114706 ;PMID: 34731554Digital Resources/Online E-Resources |
| 13 |
Material Type: Article
|
|
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialThe Lancet Infectious Diseases, 2021-02, Vol.21 (2), p.181-192 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2021. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30843-4 ;PMID: 33217362Digital Resources/Online E-Resources |
| 14 |
Material Type: Article
|
|
COVID-19: towards controlling of a pandemicThe Lancet, 2020-03, Vol.395 (10229), p.1015-1018 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30673-5 ;PMID: 32197103Digital Resources/Online E-Resources |
| 15 |
Material Type: Article
|
|
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBBNew England Journal of Medicine, 2023-01, Vol.388 (1), p.89-91 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2214302 ;PMID: 36476720Digital Resources/Online E-Resources |
| 16 |
Material Type: Article
|
|
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyThe Lancet (British edition), 2021-01, Vol.397 (10270), p.220-232 [Peer Reviewed Journal]Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32656-8 ;PMID: 33428867Full text available |
| 17 |
Material Type: Article
|
|
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020-03, Vol.395 (10229), p.1054-1062 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30566-3 ;PMID: 32171076Digital Resources/Online E-Resources |
| 18 |
Material Type: Article
|
|
Humoral immune evasion of the omicron subvariants BQ.1.1 and XBBThe Lancet infectious diseases, 2023-01, Vol.23 (1), p.30-32 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00816-7 ;PMID: 36495917Full text available |
| 19 |
Material Type: Article
|
|
The tangled history of mRNA vaccinesNature (London), 2021-09, Vol.597 (7876), p.318-324 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Sep 16, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-02483-w ;PMID: 34522017Full text available |
| 20 |
Material Type: Article
|
|
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050The Lancet (British edition), 2021-10, Vol.398 (10308), p.1317-1343 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01258-7 ;PMID: 34562388Full text available |
Results 1 - 20 of 11,559 for All Library Resources
Sorted by:
Sorted by:
PopularityOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2005 (9)
- 2005 To 2013 (6)
- 2014 To 2017 (4)
- 2018 To 2021 (7,409)
- After 2021 (4,132)
-
More options
New Records
Resource Type
- Newsletter Articles (9,278)
- Newspaper Articles (981)
- Articles (850)
- Web Resources (219)
- magazinearticle (181)
- Reports (31)
- Text Resources (12)
- Conference Proceedings (5)
- Reviews (2)
-
More options
Subject
- Medical Research (11,494)
- Covid-19 (9,366)
- Pandemics (5,192)
- Covid-19 Vaccines (3,045)
- Severe Acute Respiratory Syndrome Coronavirus 2 (2,629)
- Clinical Trials (2,184)
- Collaboration (1,972)
- Vaccines (1,668)
- Pharmaceutical Industry (1,664)
- Laboratories (1,501)
- Earnings Per Share (1,496)
- Net Losses (1,495)
- Biotechnology Industry (1,463)
- Stockholders (1,406)
- Manufacturing (1,116)
- Disease Transmission (1,096)
- Form 10-K (1,073)
-
More options
Databases
- ProQuest Central (11,548)
- DOAJ Directory of Open Access Journals (315)
- Coronavirus Research Database (301)
- ROAD: Directory of Open Access Scholarly Resources (278)
- PubMed Central (231)
- MEDLINE (204)
- GFMER Free Medical Journals (197)
- ProQuest One Psychology (143)
- Springer Nature OA/Free Journals (44)
- HighWire Press (Free Journals) (43)
- Public Library of Science (PLoS) (39)
- Freely Accessible Journals (28)
- U.S. Government Documents (18)
- Wiley-Blackwell Open Access Titles (18)
- BMJ Open Access Journals (15)
- Journals@Ovid Open Access Journal Collection Rolling (10)
- Centers for Disease Control and Prevention (8)
- Emerald Open Access (7)
- Cambridge Wholly Gold Open Access Journals (5)
- Digital Library of the Commons (5)
-
More options
Language
- English (11,558)
- Japanese (29)
- Urdu (12)
- Spanish (2)
- Portuguese (1)
-
More options
Journal Title
- Asia News Monitor (146)
- Biospectrum (58)
- Congressional Documents And Publications (109)
- Fair Disclosure Wire (70)
- Nature (31)
- New York Times (31)
- Stat (52)
- The New York Times (50)
- The Wall Street Journal. Eastern Edition (66)
- The Washington Post (50)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||